헬리코박터 파일로리 비침습적 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Helicobacter Pylori Non-Invasive Testing Market size is expected to reach USD 1003.01 Million in 2034 from USD 660.00 Million (2025) growing at a CAGR of 4.76% during 2026-2034.

The global Helicobacter pylori non-invasive testing market is growing steadily due to the rising prevalence of gastrointestinal infections and increasing demand for convenient diagnostic methods. Helicobacter pylori is a bacterium that can cause stomach ulcers and is associated with certain types of gastric cancer. Non-invasive testing methods such as breath tests, stool antigen tests, and blood tests are widely used for diagnosis.

A major driver of this market is the increasing awareness of gastrointestinal health and the importance of early diagnosis. Non-invasive diagnostic tests are preferred because they are safer, more comfortable for patients, and easier to perform compared to invasive procedures such as endoscopy. Additionally, advancements in diagnostic technologies are improving test accuracy and reliability.

In the future, the Helicobacter pylori non-invasive testing market is expected to expand as healthcare providers emphasize early detection and preventive care. Growing healthcare investments and improved diagnostic infrastructure will support the adoption of advanced testing methods. Increasing awareness about gastrointestinal diseases is also expected to drive market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Serology Test
• Stool Antigen Test
• Urea Breath Test

By Test Type

• Laboratory-based Tests
• Point-of-Care Tests

By End-User

• Hospitals
• Clinics
• Diagnostic Laboratories

COMPANIES PROFILED

• DiaSorin SpA, Meridian Bioscience, Inc, Exalenz Bioscience Ltd, Abbott, Thermo Fisher Scientific, Biomerica, Inc, Certest Biotec SL, Sekisui Diagnostics, Coris BioConcept, Shenzhen Zhonghe Headway BioSci Tech Co, Ltd, Alere, BioRad Laboratories, Inc, Cardinal Health, Fisher Scientific, Quidel Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Serology Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Stool Antigen Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Urea Breath Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Laboratory-based Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Point-of-Care Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Test Type
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Test Type
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Test Type
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Test Type
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Test Type
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DiaSorin S.p.A
  • 9.2.2 Meridian BioscienceInc
  • 9.2.3 Exalenz Bioscience Ltd
  • 9.2.4 Abbott
  • 9.2.5 Thermo Fisher Scientific
  • 9.2.6 BiomericaInc
  • 9.2.7 Certest Biotec S.L
  • 9.2.8 Sekisui Diagnostics
  • 9.2.9 Coris BioConcept
  • 9.2.10 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
  • 9.2.11 Alere
  • 9.2.12 Bio-Rad LaboratoriesInc
  • 9.2.13 Cardinal Health
  • 9.2.14 Fisher Scientific
  • 9.2.15 Quidel Corporation